The following discussion contains forward-looking statements that involve risks
and uncertainties. Our actual results may differ materially from those discussed
in the forward-looking statements as a result of various factors, including
those set forth in Part I, Item 1A, "Risk Factors," and "Note Regarding
Forward-Looking Statements" included elsewhere in this report. The following
discussion and analysis of our financial condition and results of operations
should be read in conjunction with our audited consolidated financial statements
and related notes included elsewhere in this report, as well as the information
presented under "Selected Financial Data."
Overview
Beyond Meat is one of the fastest growing food companies in the United States,
offering a portfolio of revolutionary plant-based meats. We build meat directly
from plants, an innovation that enables consumers to experience the taste,
texture and other sensory attributes of popular animal-based meat products while
enjoying the nutritional and environmental benefits of eating our plant-based
meat products. Our brand commitment, "Eat What You Love," represents a strong
belief that there is a better way to feed our future and that the positive
choices we all make, no matter how small, can have a great impact on our
personal health and the health of our planet. By shifting from animal-based meat
to plant-based meat, we can positively impact four growing global issues: human
health, climate change, constraints on natural resources and animal welfare. The
success of our breakthrough innovation model and products has allowed us to
appeal to a broad range of consumers, including those who typically eat
animal-based meats, positioning us to compete directly in the $1.4 trillion
global meat industry.
We sell a range of plant-based products across the three main meat platforms of
beef, pork and poultry. As of December 31, 2020, our products were available at
approximately 122,000 retail and foodservice outlets in more than 80 countries
worldwide, across mainstream grocery, mass merchandiser, club, convenience
store, and natural retailer channels, and various food-away-from-home channels,
including restaurants, foodservice outlets and schools. To make plant-based meat
accessible to more consumers, in August 2020, we launched an e-commerce site and
began offering our products direct to consumers in bulk packs, mixed product
bundles, limited-time offers, and trial packs.
On May 6, 2019, we completed our IPO, in which we sold 11,068,750 shares. The
shares began trading on the Nasdaq Global Select Market on May 2, 2019. The
shares were sold at a public offering price of $25.00 per share for net proceeds
of approximately $252.4 million, after deducting underwriting discounts and
commissions of $19.4 million and issuance costs of approximately $4.9 million
payable by us. Upon the closing of the IPO, all outstanding shares of our
convertible preferred stock automatically converted into 41,562,111 shares of
common stock on a one-for-one basis, and warrants exercisable for convertible
preferred stock were automatically converted into warrants exercisable for
160,767 shares of common stock.
On August 5, 2019, we completed our Secondary Offering, in which we sold 250,000
shares. The shares were sold at a public offering price of $160.00 per share for
net proceeds to the Company of approximately $37.4 million, after deducting
underwriting discounts and commissions of $1.5 million and issuance costs of
approximately $1.1 million payable by us. Total Secondary Offering costs paid in
2019 were approximately $2.2 million, of which approximately $1.1 million was
capitalized to reflect the costs associated with the issuance of new shares and
offset against proceeds from the Secondary Offering. We did not receive any
proceeds from the sale of common stock by the selling stockholders in the
Secondary Offering.
The consolidated financial statements for the year ended December 31, 2020
include the accounts of the Company and its foreign subsidiaries, Beyond Meat EU
B.V. and BYND JX. All inter-company balances and transactions have been
eliminated.
Subsequent to the year ended December 31, 2020, on January 25, 2021, we entered
into The PLANeT Partnership, LLC, a joint venture with PepsiCo, Inc., to
develop, produce and market innovative snack and
                                       58
--------------------------------------------------------------------------------

beverage products made from plant-based protein. We believe the joint venture
will allow us to reach more consumers by entering new product categories and
distribution channels, increasing accessibility to plant-based protein around
the world.
Our primary production facilities are located in Columbia, Missouri, and
research and development and administrative offices are located in El Segundo,
California. In addition to our own production facilities, we use
co-manufacturers in various locations in the United States, Canada and the
Netherlands. In the second quarter of 2020, we acquired our first manufacturing
facility in Europe located in Enschede, the Netherlands. This facility completed
operational testing of dry blend production in late 2020 and is expected to
begin commercial trial runs in the second quarter of 2021. We also announced the
official opening of a new co-manufacturing facility, built by our distributor in
the Netherlands, to be used for Beyond Meat production. In the third quarter of
2020, we and BYND JX entered into an investment agreement and related factory
leasing contract to design and develop manufacturing facilities in the Jiaxing
Economic & Technological Development Zone to manufacture plant-based meat
products under the Beyond Meat brand in China. Renovations in the leased
facility commenced at the end of 2020 with trial production expected in the
first quarter of 2021 and full-scale end-to-end production expected by the end
of the second quarter of 2021.
On October 30, 2020, we acquired certain assets including land, building,
manufacturing equipment and assembled workforce from one of our former
co-manufacturers for cash consideration of $14.5 million, subject to adjustment
for customary prorations, transfer taxes, escrow holdbacks and other
adjustments. Expenses related to this acquisition amounted to $1.0 million. As
part of this transaction, we also acquired an assembled workforce of
approximately 180 employees. We are using this manufacturing facility primarily
for the production of our finished goods. See   Note 5  , Asset Acquisition, to
the Notes to Consolidated Financial Statements included elsewhere in this
report.
Subsequent to the year ended December 31, 2020, on January 14, 2021, we entered
into a 12-year lease with two 5-year renewal options to house our corporate
headquarters, lab and innovation space in El Segundo, California. See   Note
14  , Subsequent Events, to the Notes to Consolidated Financial Statements
included elsewhere in this report.
Our sales growth in 2020 was negatively impacted by COVID-19. Net revenues
increased to $406.8 million in 2020 from $297.9 million in 2019 and $87.9
million in 2018, representing a 115% compound annual growth rate over a two-year
period, compared to a 202% compound growth rate over a two-year period in 2019.
We have generated losses from inception. Net loss in 2020, 2019 and 2018 was
$52.8 million, $12.4 million and $29.9 million, respectively, as we invested in
innovation and growth of our business.
We operate on a fiscal calendar year, and each interim quarter is comprised of
one 5-week period and two 4-week periods, with each week ending on a Saturday.
Our fiscal year always begins on January 1 and ends on December 31. As a result,
our first and fourth fiscal quarters may have more or fewer days included than a
traditional 91-day fiscal quarter.
Impact of COVID-19 on Our Business

The COVID-19 pandemic has had, and we expect will continue to have certain
negative impacts on our business. COVID-19 has led governments and other
authorities around the world to implement significant measures intended to
control the spread of the virus, including social distancing measures, business
closures or restrictions on operations, quarantines and travel bans. While some
of these restrictions have been lifted or eased in many jurisdictions as the
rates of COVID-19 infections have decreased or stabilized, a resurgence of
COVID-19 and the discovery of various new COVID-19 variants in some markets has
slowed, halted or reversed the reopening process altogether.
In the fourth quarter of 2020, the FDA approved the distribution of various
COVID-19 vaccines for emergency use. Other COVID-19 vaccines have also been
approved for emergency use in other countries or are pending approval in the
U.S. While the rollout of the vaccines is currently underway in the United
States, we expect that it will take significant time before the vaccines are
widely available on a significant scale.
                                       59
--------------------------------------------------------------------------------

As government authorities around the world continue to implement significant
measures intended to control the spread of the virus and institute restrictions
on commercial operations, while at the same time rolling our vaccines and
implementing multi-step policies with the goal of re-opening certain markets, we
are working to ensure our compliance while also maintaining business continuity
for essential operations in our facilities. We have established a
cross-functional task force that meets regularly and continually monitors and
tracks relevant data including guidance from local, national and international
health agencies. This task force works closely with our senior leadership and is
instrumental in making critical, timely decisions and is committed to continuing
to communicate to our employees as more information is available to share.
While our manufacturing facilities remain operational, beginning in March 2020
employees at our corporate headquarters began working remotely. For essential
activities at our Manhattan Beach Project Innovation Center, we are strictly
limiting the number of employees allowed in the building and have implemented
physical distancing protocols, mandatory face coverings, temperature screening
of all personnel entering the site, and comprehensive preventative hygienic
measures to support the health and safety of our employees. We expect our
corporate headquarters employees to remain working remotely pending further
notice and guidelines from local, state and federal agencies. At our
manufacturing facilities, we have implemented a series of physical distancing
and hygienic practices to further support the health and safety of our
manufacturing employees. Our manufacturing employees are all being monitored for
COVID-19 symptoms, including temperature screening of all personnel entering the
site; and are following strict COVID-19 suggested Personal Protective Equipment
guidelines per United States Centers for Disease Control and World Health
Organization, including mandatory face coverings, increased hand washing and
significantly increased sanitation of hard surfaces. All non-essential
company-sponsored travel has been suspended and field marketing activities have
been curbed due to the COVID-19-related restrictions.
COVID-19 had a significant negative impact on our foodservice channel net
revenues in 2020. For the year ended December 31, 2020, foodservice channel net
revenues were $106.2 million compared to $153.1 million in the prior year.
Various regions around the world implemented stay-at-home orders, social
distancing measures and various restrictions on commercial operations, resulting
in the closure or limited operations of many of our foodservice customers. Such
closures or scaled back operations have also resulted in delays in tests or
launches of our products among our foodservice customers and negatively impacted
the rate of our growth. Although certain of these restrictions have been lifted
pursuant to multi-step reopening plans and exceptions to allow for carry-out and
delivery, which enabled certain of our customers to continue to generate
business, we continue to experience a significant deterioration in sales to
foodservice customers. Excluding our sales to large QSR customers, our
foodservice channel has broad exposure to certain markets within that channel
that have been disproportionately affected by COVID-19. These include, among
others: amusement parks; academic institutions; hospitality; corporate catering
services; movie theaters; sports arenas; and bars and pubs. As such, we continue
to expect recovery in our foodservice channel net revenues to generally lag the
broader foodservice sector.
In response to the recent COVID-19 resurgence and the discovery of new COVID-19
variants in some markets, new lockdowns, curfews and other restrictive measures
are being imposed which have slowed, halted or reversed the reopening process
altogether, and may adversely impact the foodservice recovery. We continue to
partner with our QSR and foodservice customers during this challenging
environment. During 2020, we offered promotional programs to many of our
foodservice partners to allow them to offer our products to consumers at reduced
price points or on other promotional terms. While we began to see some
improvement in demand in our foodservice channel during the third and fourth
quarters of 2020, amid relaxed stay-at-home orders in some states, the
environment remains highly uncertain given the ongoing pandemic and recent
COVID-19 resurgence and the discovery of new COVID-19 variants. As a result, it
is unclear how long it will take for foodservice demand to return to
pre-pandemic levels, if at all. We expect revenues in our foodservice channel
will continue to be negatively impacted in 2021.
At the same time while foodservice channel net revenues declined, our retail
channel net revenues increased. During the second quarter of 2020, we
experienced a meaningful increase in retail demand as consumers shifted toward
more at-home consumption. In response to the deterioration in the foodservice
                                       60
--------------------------------------------------------------------------------

channel and the significant shift in consumer preferences to retail, beginning
in the second quarter of 2020 and continuing into the beginning of the third
quarter of 2020, we re-purposed and re-routed a certain portion of our existing
foodservice inventory into retail SKUs. These activities led to increased net
revenues in our retail channel but negatively impacted our gross profit and
gross margin due to increased expenses associated with such activities,
additional inventory reserves and the write-off of unrecoverable portions of the
original foodservice inventory items.
Following the retail surge in the second quarter of 2020 amid panic buying in
response to COVID-19, the level of retail demand meaningfully slowed during the
second half of 2020 consistent with broader market trends across grocery
foodstuffs and the plant-based meat category as stay-at-home orders and
commercial restrictions were relaxed. Our net revenues in the retail channel
during the second half of 2020, as compared to the prior-year period, were
primarily driven by our expansion in total retail outlets, higher sales velocity
at existing retail outlets and new product introductions. We also continued to
offer promotional and reduced pricing to certain of our retail customers and
higher trade discounts in the second half of 2020 to encourage greater consumer
trial and adoption of our products. As COVID-19 rates surge in numerous regions
of the world, the environment is continuously evolving and remains highly
uncertain. It is therefore difficult to predict the level of retail demand going
forward.
For the year ended December 31, 2020, our retail and foodservice channels
accounted for approximately 73.9% and 26.1% of our net revenues, respectively.
For the year ended December 31, 2019, our retail and foodservice channels
accounted for approximately 48.6% and 51.4% of our net revenues, respectively.
For the year ended December 31, 2020, our U.S. and international channels
accounted for approximately 79.9% and 20.1% of our net revenues, respectively.
For the year ended December 31, 2019, our U.S. and international channels
accounted for approximately 67.1% and 32.9% of our net revenues, respectively.
The change in mix of our distribution channels has been significant since the
start of the COVID-19 pandemic, which is likely to continue to cause fluctuation
in our quarterly results pending its duration, magnitude and effects.
In response to the COVID-19 pandemic, in the second quarter of 2020 we undertook
our Feed A Million+ campaign, where we, with the support of our brand
ambassadors and other partners, donated and distributed more than one million
Beyond Burgers and nourishing meals at no cost to food banks, healthcare
workers, frontline responders and communities in need across the country.
At December 31, 2020, our inventory balances increased 49% compared to the
levels at December 31, 2019, primarily due to a 127% increase in raw materials
and packaging, specifically our core pea protein isolate received pursuant to
agreed-upon delivery schedules to meet our anticipated product demand which did
not materialize as expected. We also incurred $4.8 million in costs attributable
to COVID-19 from inventory write-offs and reserves associated with foodservice
products determined to be unsalable.
We source ingredients from multiple suppliers from around the world. We also
maintain inventory positions near our manufacturing operations, as well as floor
stock agreements with many of our vendors. With respect to pea protein, given
the nature of our contractual commitments, our volume deliveries are front
loaded during the year in anticipation of higher demand levels during the summer
season. Given that we scaled back our production in response to COVID-19 and to
reduce our existing finished goods and work in process inventory levels, we have
seen an increase in our pea protein stocks. However, in light of the expected
shelf life of our pea protein raw materials, we do not believe there is a risk
of inventory obsolescence of these raw materials at this time.
It is challenging to estimate the extent of the adverse impact of the COVID-19
pandemic on our results of operations, due to continued uncertainty regarding
the duration, magnitude and effects of the COVID-19 pandemic (including any
resurgences), impact of the new COVID-19 variants, rollout and uptake of the
COVID-19 vaccines and the public's willingness to receive them, potential supply
chain or manufacturing disruptions, and the magnitude of reduced customer
traffic at our foodservice customers, or the extent to which this reduction may
be offset by increased retail demand, or increasing consumer awareness of the
benefits of plant-based meat products. We also are unable to predict whether the
increase in demand by our retail
                                       61
--------------------------------------------------------------------------------

customers will resume at the levels experienced in the second quarter of 2020 or
continue to be subject to the downward pressure seen in the second half of 2020.
While the ultimate health and economic impact of COVID-19 is highly uncertain,
we expect that our business operations and results of operations, including our
net revenues, gross profit, gross margin, earnings and cash flows, will be
adversely impacted through 2021, including as a result of:
•continued weak demand in the foodservice channel from decreased foot traffic in
foodservice establishments and the level of demand shift from foodservice to
retail business;
•increased cost of goods sold and increased promotional programs and trade
discounts to our retail and foodservice customers resulting in negative impacts
on our gross margins;
•potential disruption to the supply chain caused by distribution and other
logistical issues;
•potential disruption or closure of our facilities or those of our suppliers or
co-manufacturers due to employee contraction of COVID-19;
•the timing and success of strategic partnership launches and resumption of any
expansion plans for our product lines for those QSR customers who are in trial
or test phase;
•reduced consumer confidence and consumer spending (including as a result of
lower discretionary income due to unemployment or reduced or limited work as a
result of measures taken in response to the pandemic), including spending to
purchase our products; and negative trends in consumer purchasing patterns due
to consumers' disposable income, credit availability and debt levels;
•continued foodservice customer closures (including re-closures in connection
with resurgences of COVID-19) or further reduced operations;
•our ability to introduce new foodservice products as QSR and other partners
look to simplify menu offerings as a result of the pandemic;
•changes in the retail landscape, including the timing and level of trade and
promotion discounts, our ability to grow market share and increase household
penetration, repeat buying rates and purchase frequency, and our ability to
maintain and increase sales velocity of our products;
•the pace and success of new product introductions;
•the uncertain economic and political outlook in the U.S. and worldwide;
•uncertainty in the length of recovery time for the U.S. and world economies;
and
•disruptions in our ability to expand to new international locations.
In 2020, we focused on navigating these recent challenges presented by COVID-19
through offensive measures, such as switching foodservice production lines over
to retail products, selling retail value packs and offering aggressive pricing
with a strategic opportunity to encourage consumer trials, as well as defensive
measures focused on reducing or delaying discretionary spending in areas where
effectiveness has been impeded by the pandemic, and streamlining operations,
including furloughs and headcount reductions in light of inventory levels,
demand shifts and company-wide capacity planning. In 2021, we may take similar
actions, if necessary, which will continue to negatively impact our gross
margins and profitability into 2021. Future events and effects related to
COVID-19 cannot be determined with precision and actual results could
significantly differ from estimates or forecasts.
                                       62
--------------------------------------------------------------------------------

Components of Our Results of Operations and Trends and Other Factors Affecting
Our Business
Net Revenues
We generate net revenues primarily from sales of our products to our customers
across mainstream grocery, mass merchandiser, club, convenience store, and
natural retailer channels, and various food-away-from-home channels, including
restaurants, foodservice outlets and schools, mainly in the United States. To
make plant-based meat accessible to more consumers, in August 2020, we launched
an e-commerce site and began offering our products direct to consumers in bulk
packs, mixed product bundles, limited-time offers, and trial packs.
Effective January 1, 2020, we began presenting net revenues by geography and
distribution channel as follows:

Distribution Channel                       Description
U.S. Retail                                Net revenues from retail sales to the U.S. market(1)
U.S. Foodservice                           Net revenues from restaurant and foodservice sales to the U.S.
                                           market
International Retail                       Net revenues from retail sales

to international markets, including

Canada
International Foodservice                  Net revenues from restaurant and foodservice sales to
                                           international markets, including Canada


____________

(1) Includes net revenues from direct-to-consumer sales.



Net revenues from sales to the Canadian market, previously included with net
revenues from sales to the U.S. market, have been reclassified to International
net revenues. Prior period amounts have been recast to conform to the current
period presentation. The foregoing change in presentation had no impact on our
net revenues, results of operations or cash flows.
Effective January 1, 2020, we also eliminated the presentation of net revenues
by platform as it is no longer material to an understanding of our financial
results. Previously, we presented net revenues by platform for our
"ready-to-cook" or fresh platform, and "ready-to-heat" or frozen platform. Gross
revenues from sales of products in our frozen platform were 5.5% of gross
revenues in the year ended December 31, 2019, as compared to 16.3% of gross
revenues in the year ended December 31, 2018.
The following table presents our 2019 quarterly net revenues by channel
(unaudited):

                                                         Three Months Ended
                                   March 30,      June 29,      September 28,       December 31,
(in thousands)                       2019           2019             2019               2019
U.S.:
Retail                            $  19,461      $ 30,531      $       44,170      $      35,221
Foodservice                           8,834        16,504              18,359             26,675
U.S. net revenues                    28,295        47,035              62,529             61,896
International:
Retail                                  118         3,589               6,295              5,424
Foodservice                          11,793        16,627              23,137             31,159
International net revenues           11,911        20,216              29,432             36,583
Net revenues                      $  40,206      $ 67,251      $       91,961      $      98,479



                                       63

--------------------------------------------------------------------------------

The following factors and trends in our business have driven net revenue growth
over prior periods and are expected to be key drivers of our net revenue growth,
subject to the ultimate duration, magnitude and effects of COVID-19:
•increased penetration across our retail channel, including mainstream grocery,
mass merchandiser, club, convenience store, and natural retailer channels, and
our foodservice channel, including increased desire by foodservice
establishments, including large full service restaurants and/or global QSR
customers, to add plant-based products to their menus and to highlight these
offerings;
•distribution expansion, increased sales velocity, household penetration and
repeat buying rates across our channels;
•increased international sales of our products across geographies, markets and
channels as we continue to grow our numbers of international customers;
•our continued innovation and product commercialization, including enhancing
existing products and introducing new products, such as Beyond Meatballs, Beyond
Breakfast Sausage Patties and Beyond Breakfast Sausage Links, across our
plant-based platforms that appeal to a broad range of consumers, including those
who typically eat animal-based meat;
•enhanced marketing efforts as we continue to build our brand, amplify our value
proposition around taste, health and sustainability, serve as a best-in-class
partner to strategic and other QSR customers to support product development and
category management, and drive consumer adoption of our products, including
scaling our Go Beyond marketing campaign, which seeks to mobilize our
ambassadors to welcome consumers to the brand, define the category and remain
its leader, and the launch of our What if We all Go Beyond? brand anthem,
inviting consumers to see how over time through small changes, such as what you
put at the center of your plate, there can be a meaningful collective impact on
human health and the health of our planet;
•overall market trends, including growing consumer awareness and demand for
nutritious, convenient and high protein plant-based foods; and
•increased production levels as we scale production to meet demand for our
products across our distribution channels both domestically and internationally.
In addition to the factors and trends above, we expect the following to
positively impact net revenues going forward, subject to the ultimate duration,
magnitude and effects of COVID-19:
•expansion of our own internal production facilities domestically and abroad to
produce our woven proteins, blends of flavor systems and binding systems, and
finished goods, while pursuing additional relationships with co-manufacturers;
and
•localized production and third-party partnerships to increase the availability
and speed with which we can get our products to customers internationally.
We distribute our products internationally in more than 80 countries worldwide
as of December 31, 2020. In addition to our own production facilities, we use
co-manufacturers in various locations in the United States, Canada and the
Netherlands. International net revenues decreased 16.5% in the year ended
December 31, 2020, as compared 2019, primarily due to the decline in
international foodservice net revenues attributable to COVID-19.
As we seek to continue to rapidly grow our net revenues, we face several
challenges. The extent of COVID-19's effect on our operational and financial
performance will depend on future developments, including the duration, spread
and intensity of COVID-19 (including any resurgences), impact of the new
COVID-19 variants and the rollout and uptake of COVID-19 vaccines, and the level
of social and economic restrictions imposed in the United States and abroad in
an effort to curb the spread of the virus, all of which are uncertain
                                       64
--------------------------------------------------------------------------------

and difficult to predict considering the rapidly evolving landscape. For
example, the impact of COVID-19 on any of our suppliers, co-manufacturers,
distributors or transportation or logistics providers may negatively affect the
price and availability of our ingredients and/or packaging materials and impact
our supply chain. Additionally, if we are forced to scale back hours of
production or close our production facilities or our Manhattan Beach Project
Innovation Center in response to COVID-19, we expect our business, financial
condition and results of operations would be materially adversely affected. In
addition, our growth strategy to expand our operations internationally may be
impeded. We expect to also continue to be impacted by decreased customer and
consumer demand as a result of event cancellations and social distancing,
government-imposed restrictions on public gatherings and businesses, shelter-in
place orders and temporary restaurant and retail store closures and operating
restrictions. The uncertainty created by COVID-19 significantly increases the
difficulty in forecasting operating results and strategic planning. As a result,
it is not currently possible to ascertain the overall impact of COVID-19 on our
business, results of operations, financial condition or liquidity. However, the
pandemic has had and may continue to have a material adverse impact on our
business, results of operations, financial condition and cash flows and may
adversely impact the trading price of our common stock. While the ultimate
economic impact of the COVID-19 pandemic is highly uncertain, we expect that the
adverse impact of COVID-19 pandemic on our business operations and results of
operations, including our net revenues, gross profit, gross margin, earnings and
cash flows, will continue into 2021. Future events and effects related to the
COVID-19 pandemic cannot be determined with precision and actual results could
significantly differ from estimates or forecasts.
We routinely offer sales discounts and promotions through various programs to
customers and consumers. These programs include rebates, temporary on-shelf
price reductions, buy-one-get-one-free programs, off-invoice discounts, retailer
advertisements, product coupons and other trade activities. We anticipate that
we will need to continue to offer more trade and promotion discounts to both our
retail and foodservice customers, to drive increased consumer trial and in
response to COVID-19. The expense associated with these discounts and promotions
is estimated and recorded as a reduction in total gross revenues in order to
arrive at reported net revenues. We anticipate that these promotional activities
will impact our net revenues as well as negatively impact our gross margins and
profitability and that changes in such activities will impact period-over-period
results.
In addition, because we do not have any purchase commitments from our
distributors or customers, the amount of net revenues we recognize will vary
from period to period depending on the volume, and the channels through which
our products are sold, causing variability in our results.
We expect to face increasing competition across all channels, especially as
additional plant-based protein product brands continue to enter the marketplace.
Gross Profit
Gross profit consists of our net revenues less cost of goods sold. Our cost of
goods sold primarily consists of the cost of raw materials and ingredients for
our products, direct labor and certain supply costs, co-manufacturing fees,
in-bound and internal shipping and handling costs incurred in manufacturing our
products, plant and equipment overhead, depreciation and amortization expense,
as well as the cost of packaging our products. In anticipation of future growth,
we have had to very quickly scale production and expand our sources of supply
for our core protein inputs such as pea protein. Our growth has also
significantly increased facility and warehouse utilization rates.
We intend to continue to increase our production capabilities at our two
in-house manufacturing facilities in Columbia, Missouri, while expanding our
co-manufacturing capacity and exploring additional production facilities
domestically and abroad. In the second quarter of 2020, we acquired our first
manufacturing facility in Europe located in Enschede, the Netherlands. This
facility completed operational testing of dry blend production in late 2020 and
is expected to begin commercial trial runs in the second quarter of 2021. In
addition, in June 2020 we announced the official opening of a new
co-manufacturing facility, built by our distributor in the Netherlands, to be
used for Beyond Meat production. In the third quarter of 2020, we and BYND JX
entered into an investment
                                       65
--------------------------------------------------------------------------------

agreement and related factory leasing contract to design and develop
manufacturing facilities to manufacture plant-based meat products under the
Beyond Meat brand in China. Renovations in the leased facility commenced at the
end of 2020 with trial production expected in the first quarter of 2021 and
full-scale end-to-end production expected by the end of the second quarter of
2021. On October 30, 2020, we acquired certain assets including land, building,
manufacturing equipment and assembled workforce from one of our former
co-manufacturers. We are using this manufacturing facility for the production of
our finished goods. See   Note     5  , Asset Acquisition, to the Notes to
Consolidated Financial Statements included elsewhere in this report. Acquisition
of these assets is expected to allow us to reduce manufacturing and packaging
costs through vertical integration and provide opportunities for us to test new
processes and scale new products more quickly. As a result of these expansion
initiatives, we expect our cost of goods sold in absolute dollars to increase to
support our growth.
In addition, in response to the deterioration in the foodservice channel and the
significant shift in consumer preferences to retail, beginning in the second
quarter of 2020 and continuing into the beginning of the third quarter of 2020,
we re-purposed and re-routed a certain portion of our existing foodservice
inventory into retail SKUs. In the third and fourth quarters of 2020, we wrote
off inventory associated with foodservice products determined to be unsalable.
These activities increased our costs of goods sold and negatively impacted our
gross profit and gross margin in 2020.
Although our anticipated cost reductions didn't materialize in 2020 primarily
due to the impact of COVID-19, subject to the ultimate duration, magnitude and
effects of COVID-19, we continue to expect that gross profit improvements will
be delivered primarily through improved volume leverage and throughput, greater
internalization and geographic localization of our manufacturing footprint and
expansion of our own internal production facilities domestically and abroad to
produce our woven proteins, blends of flavor systems and binding systems, and
finished goods, materials and packaging input cost reductions, tolling fee
efficiencies, and improved supply chain logistics and distribution costs. We are
also working to improve gross margin through ingredient cost savings achieved
through scale of purchasing and through expanding our co-manufacturing network
while negotiating lower tolling fees. We intend to pass some of these cost
savings on to the consumer as we pursue our goal to achieve price parity with
animal protein in at least one of our product categories by 2024.
Margin improvement may, however, may continue to be negatively impacted by our
focus on growing our customer base, volume deleveraging, aggressive pricing
strategies and increased discounting, expanding into new geographies and
markets, enhancing our production infrastructure, improving our innovation
capabilities, enhancing our product offerings and increasing consumer
engagement.
Operating Expenses
Research and Development Expenses
Research and development expenses consist primarily of personnel and related
expenses for our research and development staff, including salaries, benefits,
bonuses, and share-based compensation, scale-up expenses, and depreciation and
amortization expense on research and development assets. Our research and
development efforts are focused on enhancements to our product formulations and
production processes in addition to the development of new products. We expect
to continue to invest substantial amounts in research and development, as
research and development and innovation are core elements of our business
strategy, and we believe they represent a critical competitive advantage for us.
We believe that we need to continue to rapidly innovate in order to continue to
capture a larger market share of consumers who typically eat animal-based meats.
Over time and subject to the ultimate duration, magnitude and effects of
COVID-19, we expect these expenses to increase in absolute dollars, but to
decrease as a percentage of net revenues as we continue to scale production
volume.
                                       66
--------------------------------------------------------------------------------

Selling, General and Administrative ("SG&A") Expenses
SG&A expenses consist primarily of selling, marketing and administrative
expenses, including personnel and related expenses, share-based compensation,
outbound shipping and handling costs, non-manufacturing expense, depreciation
and amortization expense on non-manufacturing assets and other non-production
operating expenses. Marketing and selling expenses include share-based
compensation awards to brand ambassadors, advertising costs, costs associated
with consumer promotions, product samples and sales aids incurred to acquire new
customers, retain existing customers and build our brand awareness.
Administrative expenses include the expenses related to management, accounting,
legal, IT, and other office functions.
We expect SG&A expenses in absolute dollars to increase as we increase our
domestic and international expansion efforts and incur costs related to our
status as a public company. In response to COVID-19, we expect to continue to
undertake measures focused on reducing or delaying discretionary spending in
areas where effectiveness has been impeded by the pandemic, and streamlining
operations, including potential furloughs and headcount reductions, in light of
inventory levels, demand shifts and company-wide capacity planning.
We have historically had a very small sales force, with only nine full-time
sales employees as of December 31, 2017 growing to 36 full-time sales employees
as of December 31, 2020. As we continue to grow, including internationally, we
expect to expand our sales force to address additional opportunities, which
would substantially increase our selling expense. Our administrative expenses
are expected to increase as a public company with increased personnel cost in
accounting, legal, IT and compliance-related functions.
Restructuring Expenses
In May 2017, management approved a plan to terminate an exclusive supply
agreement with one of our co-manufacturers. For a discussion of these expenses,
see   Note 3  , Restructuring, and   Note 11  , Commitments and Contingencies,
to the Notes to Consolidated Financial Statements, included elsewhere in this
report.
Seasonality
Generally, we expect to experience greater demand for certain of our products
during the summer grilling season. In 2020, the impact of COVID-19, and in each
of 2019 and 2018, the strong net revenue growth compared to the previous year,
masked this seasonal impact. As our business continues to grow, we expect to see
additional seasonality effects, especially within our retail channel, with
revenue contribution from this channel tending to be greater in the second and
third quarters of the year. In an environment of uncertainty from the impact of
COVID-19, we are unable to assess the ultimate impact on the demand for our
products as a result of seasonality.
Results of Operations
The following table sets forth selected items in our statements of operations
for the periods presented:
                                                                 Year Ended December 31,
 (in thousands)                                                         2020           2019           2018
 Net revenues                                                        $ 406,785      $ 297,897      $  87,934
 Cost of goods sold                                                    284,510        198,141         70,360
 Gross profit                                                          122,275         99,756         17,574
 Research and development expenses                                      

31,535 20,650 9,587


 Selling, general and administrative expenses                          133,655         74,726         34,461
 Restructuring expenses                                                  6,430          4,869          1,515
 Total operating expenses                                              171,620        100,245         45,563
 Loss from operations                                                $ (49,345)     $    (489)     $ (27,989)



                                       67

--------------------------------------------------------------------------------

The following table presents selected items in our statements of operations as a percentage of net revenues for the respective periods presented:


                                                                                           Year Ended December 31,
                                                                            2020                    2019                    2018
Net revenues                                                                   100.0  %                100.0  %                100.0  %
Cost of goods sold                                                              69.9                    66.5                    80.0
Gross profit                                                                    30.1                    33.5                    20.0
Research and development expenses                                                7.7                     6.9                    10.9
Selling, general and administrative expenses                                    32.9                    25.1                    39.2
Restructuring expenses                                                           1.6                     1.6                     1.7
Total operating expenses                                                        42.2                    33.7                    51.8
Loss from operations                                                           (12.1) %                 (0.2) %                (31.8) %



Year Ended December 31, 2020 Compared to Year Ended December 31, 2019
Net Revenues
                                                                        Year Ended December 31,                     Change
(in thousands)                                                                                              2020               2019              Amount               %
U.S.:
Retail                                                                                                  $ 264,111          $ 129,383          $ 134,728              104.1  %
Foodservice                                                                                                60,763             70,372             (9,609)             (13.7) %
U.S. net revenues                                                                                         324,874            199,755            125,119               62.6  %
International:
Retail                                                                                                  $  36,472          $  15,426          $  21,046              136.4  %
Foodservice                                                                                                45,439             82,716            (37,277)             (45.1) %
International net revenues                                                                                 81,911             98,142            (16,231)             (16.5) %
Net revenues                                                                                            $ 406,785          $ 297,897          $ 108,888               36.6  %


Net revenues in the year ended December 31, 2020 increased by $108.9 million, or
36.6%, as compared to the prior year primarily due to an increase in volume
sold, partially offset by lower net price per pound driven by our strategic
investments in promotional activity intended to encourage greater consumer trial
and adoption and, to a lesser extent, product mix shifts as larger-pack items
carrying a lower net price per unit volume accounted for a greater proportion of
our retail net revenues compared to the prior-year period. Growth in net
revenues was primarily due to increased retail channel sales, resulting from
distribution gains both domestically and abroad, higher sales velocities at
existing retail customers, and contribution from new product introductions. The
increase in retail channel sales was largely offset by a decline in foodservice
channel sales as a result of the ongoing COVID-19 pandemic and the impact of
widespread domestic and international stay-at-home orders, social distancing
measures and various restrictions on commercial operations, resulting in the
closure or limited operations of many of our foodservice customers. Our
foodservice channel has broad exposure to, among others, hotels, academic
institutions, amusement parks, sports arenas, movie theaters, convention
centers, corporate catering services and bars and pubs, all of which have been
disproportionately impacted by COVID-19.
Net revenues from U.S. retail sales in the year ended December 31, 2020
increased $134.7 million, or 104.1%, primarily due to increases in sales of
Beyond Beef, Beyond Burger and Beyond Sausage.
                                       68
--------------------------------------------------------------------------------

Approximately 7.7% of the increase in U.S. retail sales in the year ended
December 31, 2020 was due to the introduction of Beyond Breakfast Sausage during
the second quarter of 2020.
Net revenues from U.S. foodservice sales in the year ended December 31, 2020
decreased $9.6 million, or 13.7%, primarily due to decreases in sales of Beyond
Burger, Beyond Sausage, Beyond Beef Crumble and Beyond Meatball, primarily due
to the impact of COVID-19, partially offset by increases in sales of Beyond
Breakfast Sausage and Beyond Beef. Our products were available at approximately
28,000 U.S. retail outlets and 42,000 U.S. foodservice outlets as of December
31, 2020.
Net revenues from international retail sales in the year ended December 31, 2020
increased $21.0 million, or 136.4%, primarily due to increases in sales of
Beyond Burger, Beyond Sausage and Beyond Beef, and to a lesser extent, due to
increases in sales of Beyond Breakfast Sausage, Beyond Meatballs and Beyond Beef
Crumble. Net revenues from international foodservice sales in the year ended
December 31, 2020 decreased $37.3 million, or 45.1%, primarily due to the impact
of COVID-19. Our products were available at approximately 52,000 international
retail and foodservice outlets as of December 31, 2020.
The following table presents volume of our products sold in pounds:
                                                                      Year Ended December 31,                        Change
(in thousands)                                                                                             2020                  2019                Amount                %
U.S.:
Retail                                                                                                      45,706               21,347              24,359               114.1  %
Foodservice                                                                                                 10,860               11,845                (985)               (8.3) %
International:
Retail                                                                                                       6,684                2,816               3,868               137.4  %
Foodservice                                                                                                  9,281               15,364              (6,083)              (39.6) %
Volume of products sold                                                                                     72,531               51,372              21,159                41.2  %


Cost of Goods Sold
                                        Year Ended December 31,                   Change
(in thousands)                                                             2020           2019          Amount          %
Cost of goods sold                                                      $ 284,510      $ 198,141      $ 86,369        43.6  %



Cost of goods sold increased by $86.4 million, or 43.6%, in 2020 as compared to
the prior year, primarily due to the increase in the sales volume of our
products. The increase in cost of goods sold was also due to lower absorption of
fixed overhead costs as we scaled back production to reduce inventory levels.
Cost of goods sold in 2020 included $10.8 million in write off of excess and
obsolete inventories related to the impact of COVID-19 including product
repacking activities to repurpose certain foodservice inventory, and charges and
write offs associated with foodservice products determined to be unsalable. Cost
of goods sold in 2019 included $6.4 million in write off of excess and obsolete
inventories.
Gross Profit and Gross Margin
                                     Year Ended December 31,                   Change
(in thousands)                                                           2020           2019          Amount          %
Gross profit                                                         $ 122,275       $ 99,756       $ 22,519        22.6  %
Gross margin                                                              30.1  %        33.5  %           N/A          N/A



                                       69

--------------------------------------------------------------------------------

Gross profit in 2020 was $122.3 million, or 30.1% of net revenues, as compared
to gross profit of $99.8 million, or 33.5% of net revenues, in the prior year,
an improvement of $22.5 million. The improvement in gross profit was primarily
due to an increase in the volume of products sold. The decrease in gross margin
was primarily due to lower absorption of fixed overhead production costs as we
scaled back production to reduce inventory levels in response to the lower than
anticipated customer demand in the foodservice channel due to the impact of
COVID-19. Additionally, lower net price realization resulting from higher trade
discounts also contributed to the decrease in gross margin. As disclosed in
  Note 2  , Summary of Significant Accounting Policies-Shipping and Handling
Costs, in the Notes to Consolidated Financial Statements included elsewhere in
this report, we include outbound shipping and handling costs within SG&A
expenses. As a result, our gross profit and gross margin may not be comparable
to other entities that present all shipping and handling costs as a component of
cost of goods sold.
Research and Development Expenses
                                                              Year Ended December 31,                    Change
(in thousands)                                                                                   2020              2019             Amount               %
Research and development expenses                                                             $ 31,535          $ 20,650          $ 10,885               52.7  %



Research and development expenses increased $10.9 million, or 52.7%, in 2020, as
compared to the prior year. Research and development expenses increased
primarily due to higher headcount of approximately 69 more employees, $4.0
million in higher scale-up expenses and $1.2 million in higher depreciation and
amortization expense compared to the prior year.
SG&A Expenses
                                                               Year Ended December 31,                     Change
(in thousands)                                                                                     2020              2019             Amount               %
Selling, general and administrative
expenses                                                                                       $ 133,655          $ 74,726          $ 58,929               78.9  %



SG&A expenses increased by $58.9 million, or 78.9%, in 2020, as compared to the
prior year. The increase was primarily due to $16.1 million in higher
share-based compensation expense, $14.1 million in higher salaries and related
expenses resulting from a higher headcount, $9.2 million in higher
marketing-related expenses, $3.9 million in higher legal expenses, $3.2 million
in higher broker and distributor commissions, $2.9 million in higher general
insurance costs, $2.7 million in higher expense related to product donations for
our Feed A Million+ campaign attributable to COVID-19 relief efforts, $2.0
million in higher consulting expenses, $1.4 million in higher public
company-related expenses, $1.1 million in higher postage and delivery expenses,
$1.0 million in higher outbound shipping and handling expenses, and $1.0 million
in higher information technology-related expenses. The increase in share-based
compensation expense in the year ended December 31, 2020 was primarily due to
appreciation in our stock price as well as substantially higher staffing levels
versus the prior years.
Restructuring Expenses
As a result of the termination in May 2017 of an exclusive supply agreement with
one of our co- manufacturers due to non-performance under the agreement, we
recorded restructuring expenses of $6.4 million and $4.9 million in 2020 and
2019, respectively, primarily related to legal and other expenses associated
with the dispute. As of December 31, 2020 and 2019, there were $0.8 million and
$1.1 million, respectively, in accrued unpaid liabilities associated with this
contract termination representing legal fees. We continue to incur legal fees in
connection with our ongoing efforts to resolve this dispute. See   Note 3  ,
Restructuring and   Note 11  , Commitments and Contingencies, to the Notes to
Consolidated Financial Statements, included elsewhere in this report.
                                       70
--------------------------------------------------------------------------------

Loss from Operations
Loss from operations in 2020 was $49.3 million compared to loss from operations
of $0.5 million in the prior year. This increase in loss from operations was
driven by the year-over-year increase in cost of goods sold, higher operating
expenses to support our expanded manufacturing and supply chain operations,
higher share-based compensation expense, higher administrative costs associated
with being a public company, higher restructuring expenses, and continued
investment in innovation and marketing capabilities, partially offset by the
improvement in gross profit.
Total Other Expense, Net
Total other expense, net in the year ended December 31, 2020 primarily includes
interest expense on our debt balances, loss on extinguishment of debt and
foreign currency transaction losses, partially offset by interest income. Total
other expense, net in the year ended December 31, 2019 primarily includes
interest expense on our debt balances and expense associated with the
remeasurement of our preferred stock warrant liability and common stock warrant
liability, partially offset by interest income. On May 6, 2019, in connection
with the IPO, our then outstanding warrants exercisable for convertible
preferred stock were automatically converted into warrants exercisable for
common stock. We remeasured and reclassified the common stock warrant liability
to additional-paid-in-capital in connection with the IPO and recorded $12.5
million in expense associated with the remeasurement of warrant liability in
2019.
Subsequent to the closing of the IPO, all outstanding warrants to purchase
shares of common stock were cashless exercised. No warrants were outstanding as
of December 31, 2020.
Other, net was a net expense of $0.8 million in 2020 as compared to net income
of $3.6 million in 2019. Other, net in 2020 included $1.5 million in loss on
extinguishment of our refinanced credit arrangements, partially offset by
interest income from invested cash balances. Interest income decreased to $0.8
million in the year ended December 31, 2020 from $3.9 million in the prior year.
Income Tax Expense
For 2020 and 2019, we recorded income tax expense of $72,000 and $9,000,
respectively. These amounts primarily consist of income taxes for state
jurisdictions which have minimum tax requirements. No tax benefit was provided
for losses incurred because those losses were offset by a full valuation
allowance.
Net Loss
Net loss was $52.8 million in 2020 compared to a net loss of $12.4 million in
the prior year. This increase in net loss was driven by the year-over-year
increase in operating expenses to support our expanded manufacturing and supply
chain operations, higher share-based compensation expense, higher administrative
costs associated with being a public company, higher restructuring expenses, and
continued investment in innovation and marketing capabilities, partially offset
by the improvement in gross profit. During 2020, net loss included $14.1 million
in costs attributable to COVID-19 including $6.6 million in product repacking
costs, $4.8 million in inventory write-offs and charges associated with
foodservice products determined to be unsalable and $2.7 million in product
donation costs related to our COVID-19 relief efforts, and $1.5 million of debt
extinguishment costs associated with our refinanced credit arrangements.
                                       71
--------------------------------------------------------------------------------


Year Ended December 31, 2019 Compared to Year Ended December 31, 2018
Net Revenues
                                                                        Year Ended December 31,                     Change
(in thousands)                                                                                              2019              2018              Amount                %
U.S.:
Retail                                                                                                  $ 129,383          $ 49,772          $  79,611               160.0  %
Foodservice                                                                                                70,372            20,717             49,655               239.7  %
U.S. net revenues                                                                                         199,755            70,489            129,266               183.4  %
International:
Retail                                                                                                  $  15,426          $  1,007          $  14,419             1,431.9  %
Foodservice                                                                                                82,716            16,438             66,278               403.2  %
International net revenues                                                                                 98,142            17,445             80,697               462.6  %
Net revenues                                                                                            $ 297,897          $ 87,934          $ 209,963               238.8  %


Net revenues increased by $210.0 million, or 238.8%, in 2019 as compared to 2018
primarily due to strong growth in sales volumes of products across both our
retail and our foodservice channels, driven by expansion in the number of retail
and foodservice outlets, including new strategic customers, new international
customers, higher sales velocities from our existing customers and contribution
from new products introduced in 2019.
Net revenues from retail channel increased $94.0 million, or 185.2%, primarily
due to expansion in the number of retail outlets, increased sales of the Beyond
Burger and Beyond Sausage, as well as the introduction of Beyond Beef. Net
revenues from foodservice channel increased $115.9 million, or 312.0%, primarily
due to expansion in the number of foodservice outlets, including new strategic
customers and international customers, increases in sales of the Beyond Burger,
as well as due to increased sales of Beyond Sausage and the introduction of
Beyond Beef.
The following table presents volume of our products sold in pounds:
                                                                      Year Ended December 31,                           Change
(in thousands)                                                                                             2019                        2018                Amount                 %
U.S.:
Retail                                                                                                      21,347                      8,565              12,782                149.2  %
Foodservice                                                                                                 11,845                      3,559               8,286                232.8  %
International:
Retail                                                                                                       2,816                        147               2,669              1,815.6  %
Foodservice                                                                                                 15,364                      2,971              12,393                417.1  %
Volume of products sold                                                                                     51,372    51372000         15,242              36,130                237.0  %



Cost of Goods Sold
                           Year Ended December 31,                    Change
(in thousands)               2019                2018         Amount        Percentage
Cost of goods sold   $     198,141            $ 70,360      $ 127,781          181.6  %



                                       72

--------------------------------------------------------------------------------

Cost of goods sold increased by $127.8 million, or 181.6%, in 2019 as compared
to the prior year, primarily due to the increase in the sales volume of our
products. Cost of goods sold in 2019 and 2018 included $6.4 million and $0.8
million, respectively, in write off of excess and obsolete inventories.
Gross Profit and Gross Margin
                        Year Ended December 31,                    Change
(in thousands)         2019                  2018          Amount       

Percentage


Gross profit      $    99,756             $ 17,574       $ 82,182          467.6  %
Gross margin             33.5   %             20.0  %           N/A         

N/A





Gross profit in 2019 was $99.8 million, or 33.5% of net revenues, as compared to
gross profit of $17.6 million, or 20% of net revenues, in the prior year, an
improvement of $82.2 million. The improvement in gross profit and gross margin
was primarily due to an increase in the volume of products sold, with resulting
operating leverage, and improved production efficiencies. The greater proportion
of net revenues from products with higher net selling price per pound also
contributed to the increase in gross profit. The increase in gross margin was
partially offset by temporary disruptions related to capacity expansion projects
at two co-manufacturing partners' plants in the fourth quarter of 2019. As
disclosed in   Note 2  , Summary of Significant Accounting Policies-Shipping and
Handling Costs, in the Notes to Consolidated Financial Statements included
elsewhere in this report, we include outbound shipping and handling costs within
SG&A expenses. As a result, our gross profit and gross margin may not be
comparable to other entities that present all shipping and handling costs as a
component of cost of goods sold.
Research and Development Expenses
                                          Year Ended December 31,           

Change


(in thousands)                               2019                2018         Amount       Percentage
Research and development expenses   $      20,650              $ 9,587

$ 11,063 115.4 %

Research and development expenses increased $11.1 million, or 115.4%, in 2019, as compared to the prior year. Research and development expenses increased primarily due to higher headcount, higher scale-up expenses and higher depreciation and amortization expense compared to the prior year. SG&A Expenses


                                                  Year Ended December 31,                            Change
(in thousands)                                    2019                 2018              Amount              Percentage
Selling, general and administrative
expenses                                    $      74,726          $  34,461          $  40,265                    116.8  %



SG&A expenses increased by $40.3 million, or 116.8%, in 2019, as compared to the
prior year. The increase was primarily due to $12.4 million in higher salaries,
bonuses and related expenses due to higher headcount, $10.4 million in higher
share-based compensation expense, including $3.2 million relating to equity
awards made to brand ambassadors, $4.8 million in higher outbound shipping and
handling expenses, $3.1 million in higher broker and distributor commissions,
$2.4 million in higher legal expenses primarily due to the Secondary Offering
and costs associated with being a public company, $1.9 million in higher
insurance costs, and continued investment in marketing capabilities.
Restructuring Expenses
As a result of the termination in May 2017 of an exclusive supply agreement with
one of our co-manufacturers due to non-performance under the agreement, we
recorded restructuring expenses of $4.9
                                       73
--------------------------------------------------------------------------------

million and $1.5 million in 2019 and 2018, respectively, primarily related to
legal and other expenses associated with the dispute. As of December 31, 2019
and 2018, there were $1.1 million and $0, respectively, in accrued unpaid
liabilities associated with this contract termination representing legal fees.
We continue to incur legal fees in connection with our ongoing efforts to
resolve this dispute. See   Note 3  , Restructuring and   Note 11  , Commitments
and Contingencies, to the Notes to Consolidated Financial Statements, included
elsewhere in this report.
Total Other Expense, Net
Total other expense, net primarily includes interest expense on the Company's
debt balances and expense associated with the remeasurement of our preferred
stock warrant liability and common stock warrant liability, partially offset by
interest income. On May 6, 2019, in connection with the IPO, our then
outstanding warrants exercisable for convertible preferred stock were
automatically converted into warrants exercisable for common stock. We
remeasured and reclassified the common stock warrant liability to
additional-paid-in-capital in connection with the IPO and recorded $12.5 million
in expense associated with the remeasurement of warrant liability in 2019.
Interest income in 2019 increased due to interest income from invested proceeds
from the IPO and Secondary Offering.
Subsequent to the closing of the IPO, all outstanding warrants to purchase
shares of common stock were cashless exercised. No warrants were outstanding as
of December 31, 2019.
Other, net was $3.6 million in 2019 as compared to $0.4 million in 2018
primarily due to increased interest income resulting from investment of proceeds
from the IPO and Secondary Offering.
Loss from Operations
Loss from operations in 2019 was $0.5 million compared to loss from operations
of $28.0 million in the prior year. This improvement was driven entirely by the
year-over-year increase in gross profit, partially offset by higher operating
expenses to support our expanded manufacturing and supply chain operations,
higher share-based compensation expense, higher administrative costs associated
with being a public company, higher restructuring expenses, and continued
investment in innovation and marketing capabilities.
Income Tax Expense
For 2019 and 2018, we recorded income tax expense of $9,000 and $1,000,
respectively. These amounts primarily consist of income taxes for state
jurisdictions which have minimum tax requirements. No tax benefit was provided
for losses incurred because those losses were offset by a full valuation
allowance.
Net Loss
Net loss was $12.4 million in 2019 compared to a net loss of $29.9 million in
the prior year. The decrease in net loss was primarily the result of the higher
gross profit in 2019 and interest income, partially offset by higher operating
expenses, higher share-based compensation expense, expenses associated with the
remeasurement of our preferred stock warrant liability and common stock warrant
liability in connection with the IPO, and higher interest expense.

                                       74
--------------------------------------------------------------------------------

Non-GAAP Financial Measures
We use the non-GAAP financial measures set forth below in assessing our
operating performance and in our financial communications. Management believes
these non-GAAP financial measures provide useful additional information to
investors about current trends in our operations and are useful for
period-over-period comparisons of operations. In addition, management uses these
non-GAAP financial measures to assess operating performance and for business
planning purposes. Management also believes these measures are widely used by
investors, securities analysts, rating agencies and other parties in evaluating
companies in our industry as a measure of our operational performance. These
non-GAAP financial measures should not be considered in isolation or as a
substitute for the comparable GAAP measures. In addition, these non-GAAP
financial measures may not be computed in the same manner as similarly titled
measures used by other companies.
"Adjusted EBITDA" is defined as net (loss) income adjusted to exclude, when
applicable, income tax expense (benefit), interest expense, depreciation and
amortization expense, restructuring expenses, share-based compensation expense,
expenses attributable to COVID-19, remeasurement of our warrant liability, and
Other, net, including investment income, loss on extinguishment of debt and
foreign currency transaction gains and losses.
"Adjusted EBITDA as a % of net revenues" is defined as Adjusted EBITDA divided
by net revenues.
There are a number of limitations related to the use of Adjusted EBITDA rather
than net (loss) income, which is the most directly comparable GAAP measure. Some
of these limitations are:
•Adjusted EBITDA excludes depreciation and amortization expense and, although
these are non-cash expenses, the assets being depreciated may have to be
replaced in the future increasing our cash requirements;
•Adjusted EBITDA does not reflect interest expense, or the cash required to
service our debt, which reduces cash available to us;
•Adjusted EBITDA does not reflect income tax payments that reduce cash available
to us;
•Adjusted EBITDA does not reflect restructuring expenses that reduce cash
available to us;
•Adjusted EBITDA does not reflect expenses attributable to COVID-19 that reduce
cash available to us;
•Adjusted EBITDA does not reflect share-based compensation expense and therefore
does not include all of our compensation costs;
•Adjusted EBITDA does not reflect Other, net, including investment income, loss
on extinguishment of debt and foreign currency transaction gains and losses,
that may increase or decrease cash available to us; and
•other companies, including companies in our industry, may calculate Adjusted
EBITDA differently, which reduces its usefulness as a comparative measure.

                                       75
--------------------------------------------------------------------------------

The following table presents the reconciliation of Adjusted EBITDA to its most comparable GAAP measure, net loss, as reported (unaudited):


                                                          Year Ended December 31,
(in thousands)                                                  2020            2019            2018
Net loss, as reported                                       $ (52,752)      $ (12,443)      $ (29,886)
Income tax expense                                                 72               9               1
Interest expense                                                2,576           3,071           1,128
Depreciation and amortization expense                          13,299           8,106           4,921
Restructuring expenses(1)                                       6,430           4,869           1,515

Share-based compensation expense                               27,279          12,807           2,241
Expenses attributable to COVID-19(2)                           14,137               -               -
Remeasurement of warrant liability                                  -          12,503           1,120
Other, net(3)                                                     759          (3,629)           (352)
Adjusted EBITDA                                             $  11,800       $  25,293       $ (19,312)

Net loss as a % of net revenues                                 (13.0) %         (4.2) %        (33.9) %
Adjusted EBITDA as a % of net revenues                            2.9  %          8.5  %        (22.0) %


_____________

(1) Primarily comprised of legal and other expenses associated with the dispute with a

co-manufacturer with whom an exclusive supply agreement was terminated in May 2017.See

Note 3 , Restructuring, and Note 11 , Commitments and Contingencies, to the Notes

to Consolidated Financial Statements, included elsewhere in this report. (2) In 2020, comprised of $14.1 million in costs attributable to COVID-19 consisting of

$6.6 million in product repacking costs, $4.8 million in inventory write-offs and

charges associated with foodservice products determined to be unsalable and $2.7

million in product donation costs related to our COVID-19 relief efforts. Expenses

attributable to COVID-19 in the twelve months ended December 31, 2020 include $1.2

million in product donation costs related to the Company's COVID-19 relief efforts in

the first quarter of 2020, which were not previously included in the Company's Adjusted

EBITDA calculation for the three months ended March 28, 2020 as these were deemed

immaterial to its first quarter 2020 financial results. Given the significant increase

in COVID-19-related expenses in the subsequent quarters of 2020, and to facilitate

better comparison from period to period, management determined that it was appropriate

to recast its previous first quarter 2020 Adjusted EBITDA calculation to include these

costs.

(3) Includes $1.5 million in loss on extinguishment of debt in the year ended December 31,


       2020.



Liquidity and Capital Resources
Liquidity
Our primary cash needs are for operating expenses, working capital and capital
expenditures to support the growth in our business. Prior to our IPO, we
financed our operations through private sales of equity securities and through
sales of our products. Since our inception and through our IPO, we raised a
total of $199.5 million from the sale of convertible preferred stock, including
through sales of convertible notes which were converted into preferred stock,
net of costs associated with such financings. In connection with our IPO, we
sold an aggregate of 11,068,750 shares of our common stock at a public offering
price of $25.00 per share and received approximately $252.4 million in net
proceeds.
In connection with the Secondary Offering we sold 250,000 shares of our common
stock. The shares were sold at a public offering price of $160.00 per share and
we received net proceeds of approximately $37.4 million. We did
                                       76
--------------------------------------------------------------------------------

not receive any proceeds from the sale of common stock by the selling
stockholders in the Secondary Offering. We have also entered into the credit
facilities described below with J.P. Morgan Chase ("Revolving Credit Facility").
As of December 31, 2020, we had $159.1 million in cash and cash equivalents. We
believe that our cash and cash equivalents, cash flow from operating activities
and available borrowings under our credit facilities will be sufficient to fund
our working capital and meet our anticipated capital requirements for the next
12 months. Additionally, we may also raise funds by issuing debt or equity
securities. Our future capital requirements may vary materially from those
currently planned and will depend on many factors, including the impact of
COVID-19; the number and characteristics of any additional products or
manufacturing processes we develop or acquire to serve new or existing markets;
the expenses associated with our marketing initiatives; our investment in
manufacturing and facilities to expand our manufacturing and production
capacity; the costs required to fund domestic and international growth; the
scope, progress, results and costs of researching and developing future products
or improvements to existing products or manufacturing processes; our investment
in our new headquarters campus; any lawsuits related to our products or
commenced against us, including the costs associated with our current litigation
with a former co-manufacturer, the shareholder derivative lawsuits putatively
brought on our behalf; the expenses needed to attract and retain skilled
personnel; the costs associated with being a public company; the costs involved
in preparing, filing, prosecuting, maintaining, defending and enforcing
intellectual property claims, including litigation costs and the outcome of such
litigation; and the timing, receipt and amount of sales of, or royalties on, any
future approved products, if any.
Revolving Credit Facility
On April 21, 2020, we entered into a $150 million five-year secured revolving
credit agreement ("2020 Credit Agreement") by and among the Company, the lenders
party thereto (the "Lenders") and JPMorgan Chase Bank, N.A., as the
administrative agent (the "Administrative Agent"). JPMorgan Chase Bank, N.A. and
Silicon Valley Bank acted as joint bookrunners and joint lead arrangers under
the 2020 Credit Agreement. The 2020 Credit Agreement includes an accordion
feature for up to an additional $200 million. We incurred debt issuance costs,
net of amortization, of $1.1 million in the year ended December 31, 2020 in
connection with the new revolving credit facility. The revolving credit facility
matures on April 21, 2025. See   Note     8  , Debt, to the Notes to
Consolidated Financial Statements included elsewhere in this report.
Concurrently with the effectiveness of the 2020 Credit Agreement, on April 21,
2020, we terminated the $6.0 million revolving credit line and $20.0 million
term loan facility with Silicon Valley Bank (the "SVB Credit Facilities"), and
the $5.0 million equipment loan facility with Structural Capital Investments II,
LP, as Lender, and Ocean II, PLC, LLC, as collateral agent and administrative
agent (the "Equipment Loan Facility"), and incurred an aggregate of $1.2 million
of termination, prepayment, and related fees in connection with such
terminations.
As of December 31, 2020, we had outstanding borrowings of $25.0 million and no
excess availability under the revolving credit facility. The interest rate on
outstanding borrowings at December 31, 2020 was 3.5%. We exceeded the maximum
permitted total leverage ratio financial covenant in the 2020 Credit Agreement
for the fiscal quarter and year ended December 31, 2020. Subsequent to the year
ended December 31, 2020, on February 25, 2021, we paid down our outstanding
borrowings and had no borrowings outstanding under the revolving credit
facility. Subsequent to the year ended December 31, 2020, concurrent with our
execution of the campus headquarters lease, as a security deposit, we delivered
to the landlord a letter of credit under the revolving credit facility in the
amount of $12.5 million. See   Note 14  , Subsequent Events, to the Notes to
Consolidated Financial Statements included elsewhere in this report.
Cash Flows
In the year ended December 31, 2020, approximately $114.3 million in aggregate
expenditures to purchase inventory and property, plant and equipment, acquire
assets from our former co-manufacturer, and pay loan payments net of borrowings
(including extinguishing prior credit facilities) of $6.0 million, were funded
by $116.7 million of existing cash, and approximately $3.7 million from other
operating, investing and financing activities.
                                       77
--------------------------------------------------------------------------------

The following table presents the major components of net cash flows used in and
provided by operating, investing and financing activities for the periods
indicated.
                                          Year Ended December 31,
(in thousands)                      2020           2019           2018
Cash (used in) provided by:
Operating activities             $ (39,995)     $ (46,995)     $ (37,721)
Investing activities             $ (74,900)     $ (26,164)     $ (23,242)
Financing activities             $  (1,762)     $ 294,876      $  76,199


Net Cash Used in Operating Activities
For the year ended December 31, 2020, we incurred a net loss of $52.8 million,
which was the primary reason for net cash used in operating activities of $40.0
million. Net cash used in operating activities also included $32.2 million in
net cash outflows from changes in our operating assets and liabilities,
primarily due to increase in inventory, and prepaid expenses and other current
assets, partially offset by an increase in accounts payable and a decrease in
accounts receivable. Increase in inventories, primarily due to the increase in
raw materials inventory resulting from pea protein isolate received pursuant to
agreed-upon delivery schedules to meet our anticipated product demand,
negatively impacted cash flows from operations because due to the impact of
COVID-19 the anticipated sales and the resulting cash inflows did not
materialize as expected. Net loss for the year ended December 31, 2020, included
$44.9 million in non-cash expenses primarily comprised of share-based
compensation expense, depreciation and amortization expense, non-cash lease
expense and loss on extinguishment of debt.
For the year ended December 31, 2019, we incurred a net loss of $12.4 million.
The primary reason for net cash used in operating activities of $47.0 million
was the $68.2 million in net cash outflows from changes in our operating assets
and liabilities, primarily due to increases in inventory to meet growth in
anticipated sales and to accommodate longer lead times for international
shipments, and increases in accounts receivable, partially offset by $33.7
million in non-cash expenses primarily comprised of share-based compensation
expense, change in warrant liability and depreciation and amortization expense.
For the year ended December 31, 2018, we incurred a net loss of $29.9 million,
which was the primary reason for net cash used in operating activities of $37.7
million. Net cash used in operating activities also included $16.3 million in
net cash outflows from changes in our operating assets and liabilities,
partially offset by $8.5 million in non-cash expenses primarily comprised of
depreciation and amortization expense, share-based compensation expense and
change in warrant liability.
Depreciation and amortization expense was $13.3 million, $8.1 million and $4.9
million, in 2020, 2019 and 2018, respectively.
Net Cash Used in Investing Activities
Net cash used in investing activities primarily relates to capital expenditures
to support our growth and investment in property, plant and equipment.
For the year ended December 31, 2020, net cash used in investing activities was
$74.9 million and consisted of $57.7 million in cash outflows for purchases of
property, plant and equipment, primarily driven by continued investments in
production equipment and facilities related to our capacity expansion
initiatives and international expansion, including the acquisition of a
manufacturing facility in Europe located in Enschede, the Netherlands, $15.5
million for the acquisition of assets from a former co-manufacturer,
$2.3 million in cash outflows related to property, plant and equipment purchased
for sale to co-manufacturers, and security deposits, partially offset by
proceeds from sale of assets held for sale.
For the year ended December 31, 2019, net cash used in investing activities was
$26.2 million and consisted of $23.8 million in cash outflows for purchases of
property, plant and equipment, primarily for manufacturing facility improvements
and manufacturing equipment, $2.1 million in cash outflows related to property,
plant and equipment purchased for sale to co-manufacturers, and security
deposits, partially offset by proceeds from sale of assets held for sale.
                                       78
--------------------------------------------------------------------------------

For the year ended December 31, 2018, net cash used in investing activities was
$23.2 million and consisted of $22.2 million in cash outflows for the purchases
of property, plant and equipment, manufacturing facility improvements and
manufacturing equipment, $1.0 million in cash outflows related to property,
plant and equipment purchased for sale to co-manufacturers, and security
deposits, partially offset by proceeds from sale of fixed assets.
Net Cash Provided by Financing Activities
For the year ended December 31, 2020, net cash used by financing activities was
$1.8 million primarily due to $31.0 million in extinguishment of prior credit
facilities, debt issuance costs of $1.2 million associated with our new
revolving credit facility and debt extinguishment costs of $1.2 million
associated with our refinanced credit arrangements, partially offset by $25.0
million in net proceeds to us from our revolving credit facility. Cash flows
from financing activities included $9.0 million in proceeds from stock option
exercises, partially offset by $2.3 million in payments of minimum withholding
taxes on net share settlement of equity awards, and $70,000 in payments of
finance lease obligations.
For the year ended December 31, 2019, net cash provided by financing activities
was $294.9 million primarily as a result of $254.9 million in net proceeds from
our IPO, net of issuance costs, $37.4 million in net proceeds to us from the
Secondary Offering, net of issuance costs, and $2.7 million in proceeds from
stock option exercises, partially offset by $55,000 in payments toward finance
lease obligations.
For the year ended December 31, 2018, financing activities provided $76.2
million in cash as a result of $51.3 million of proceeds from the issuance of
our Series G and H preferred stock, net of issuance costs, $20.0 million in
borrowings under our term loan facility, $6.0 million in borrowings under our
revolving credit line, $5.0 million in borrowings under an equipment loan
facility, and $1.4 million in proceeds from stock option exercises, partially
offset by cash outflows for repayment of a note with the Missouri Department of
Economic Development, and borrowings under our 2016 Revolving Credit Facility
and 2016 Term Loan Facility. The proceeds from the borrowings were used to
finance our operations.
Contractual Obligations and Commitments
Revolving Credit Facility
On April 21, 2020, we entered into the 2020 Credit Agreement. Concurrently with
the effectiveness of the 2020 Credit Agreement, on April 21, 2020, we terminated
the SVB Credit Facilities and the Equipment Loan Facility, paying off an
aggregate of $31.0 million in loan balances. See   Note 8  , Debt, to the Notes
to Consolidated Financial Statements included elsewhere in this report.
Leases
On January 1, 2020, we adopted Accounting Standards Update ("ASU") No. 2016-02,
"Leases" (Topic 842) ("ASU 2016-02") using the modified retrospective approach,
which permits application of this new guidance at the beginning of the period of
adoption, with comparative periods continuing to be reported under Accounting
Standards Codification ("ASC") No. 840 ("ASC 840"). Upon adoption of ASU
2016-02, we recognized operating lease right-of-use assets of $11.9 million
adjusted for $0.3 million previously recorded as deferred rent and $0.2 million
previously recorded as prepaid rent on our consolidated balance sheets. We also
recorded $1.4 million in current operating lease liabilities and $10.6 million
in operating lease liabilities, net of current portion.
As part of this adoption, we elected to not record operating lease right-of-use
assets or operating lease liabilities for leases with an initial term of 12
months or less. We elected to separate the lease and non-lease components on all
new or modified operating leases for the co-manufacturing class of assets for
the purpose of recording operating lease right-of-use assets and operating lease
liabilities and to combine lease and non-lease components on all new or modified
operating leases into a single lease component for all other classes of assets.
Short-term lease payments for the year ended December 31, 2020 totaled
$0.3 million.
As of December 31, 2020, we had recorded $14.6 million in operating lease
right-of-use assets, $3.1 million in current operating lease liabilities and
$11.8 million in operating lease liabilities, net of current portion.
During the year ended December 31, 2020, we amended two operating leases for our
manufacturing facilities in Columbia, Missouri, one to extend the lease term by
two years and another to include land adjacent to the
                                       79
--------------------------------------------------------------------------------

facility upon which the landlord will construct a parking lot. We also assumed
an operating lease under which we are leasing certain real property and a
building consisting of approximately 142,317 square feet in Columbia, Missouri,
for a term expiring on April 30, 2023 with no renewal options. See   Note 4 

,


Leases, to the Notes to Consolidated Financial Statements included elsewhere in
this report.
Subsequent to the year ended December 31, 2020, on January 14, 2021, we entered
into a 12-year lease with two 5-year renewal options to house our corporate
headquarters, lab and innovation space in El Segundo, California. See   Note
14  , Subsequent Events, to Notes to Consolidated Financial Statements included
elsewhere in this report.
China Investment and Lease Agreement
On September 22, 2020, we and BYND JX entered into an investment agreement with
the Administrative Committee (the "JX Committee") of the Jiaxing Economic &
Technological Development Zone (the "JXEDZ") pursuant to which, among other
things, BYND JX has agreed to make certain investments in the JXEDZ in two
phases of development and we have agreed to guarantee certain repayment
obligations of BYND JX under such agreement. During Phase 1, the Company has
agreed to invest $10.0 million in the JXEDZ through an intercompany investment
in BYND JX and BYND JX has agreed to lease a facility in the JXEDZ for a minimum
of two (2) years. In connection with such agreement, BYND JX entered into a
factory leasing contract on September 11, 2020 with an affiliate of the JX
Committee, pursuant to which BYND JX has agreed to lease and renovate a facility
in the JXEDZ for a minimum of two (2) years. In the event that the Company and
BYND JX determine, in their sole discretion, to proceed with the Phase 2
development in the JXEDZ, BYND JX has agreed in the first stage of Phase 2 to
invest $30.0 million to acquire the land use right to a state-owned land plot in
the JXEDZ to conduct development and construction of a new production facility.
Following the first stage of Phase 2, the Company and BYND JX may determine, in
their sole discretion, to permit BYND JX to invest an additional $10.0 million
to obtain a second state-owned land plot in the JXEDZ in order to construct an
additional facility thereon. See   Note 1    1  , Commitments and Contingencies,
to the Notes to Consolidated Financial Statements included elsewhere in this
report.
Purchase Commitments
On January 10, 2020, we and Roquette Frères ("Roquette") entered into a
multi-year sales agreement pursuant to which Roquette will provide us with
plant-based protein. The agreement expires on December 31, 2022; however it can
be terminated after 18 months under certain circumstances. This agreement
increases the amount of plant-based protein to be supplied by Roquette in each
of 2020, 2021 and 2022 compared to the amount supplied 2019. The plant-based
protein sourced under the supply agreement is secured on a purchase order basis
regularly, per specified minimum monthly and semi-annual quantities, throughout
the term. We are not required to purchase plant based protein in amounts in
excess of such specified minimum quantities; however the Company has the option
to increase such minimum quantities for delivery in each of 2021 and 2022. The
total annual amount purchased each year by us must be at least the minimum
amount specified in the agreement, which totals in the aggregate $154.1 million
over the term of the agreement. We also have the right to be indemnified by
Roquette in certain circumstances.
As of December 31, 2020, we had committed to purchase pea protein inventory
totaling $141.9 million, approximately $83.4 million in 2021 and $58.5 million
in 2022. In addition, as of December 31, 2020, we had approximately $19.5
million in purchase order commitments for capital expenditures primarily to
purchase machinery and equipment. Payments for these purchases will be due
within twelve months.

                                       80
--------------------------------------------------------------------------------

The following table summarizes our significant contractual obligations as of
December 31, 2020:
                                                                                  Payments Due by Period
                                                                    Less Than                                                  More Than
(in thousands)                                     Total             One Year          1-3 Years           3-5 Years           Five Years
Operating lease obligations(1)(2)               $  16,325          $   

3,455 $ 5,993 $ 2,963 $ 3,914 Financing lease obligations(3)

                        238                 80                128                  30                    -
Revolving Credit Facility(4)                       25,887             25,887                  -                   -                    -
Purchase commitments-inventory(5)                 141,863             83,362             58,501                   -                    -
Purchase commitments-assets(6)                     19,477             19,477                  -                   -                    -
Total                                           $ 203,790          $ 132,261          $  64,622          $    2,993          $     3,914


___________________
(1)Includes lease payments for our Manhattan Beach Project Innovation Center and
corporate offices in El Segundo, California, and our manufacturing facilities in
Columbia, Missouri.
(2)Excludes El Segundo Campus lease agreement entered into subsequent to the
year ended December 31, 2020. See   Note     14   , Subsequent Events, to the
Notes to Consolidated Financial Statements included elsewhere in this report.
(3)Consists of payments under various financing leases for certain equipment.
(4)Includes principal and interest accrued at a floating rate under the
Revolving Credit Facility. Subsequent to the year ended December 31, 2020, on
February 25, 2021, we paid down our outstanding borrowings and had no borrowings
outstanding under the revolving credit facility.
(5)Consists of commitments to purchase pea protein inventory.
(6)Consists of commitments to purchase property, plant and equipment.

Segment Information
We have one operating segment and one reportable segment, as our CODM, who is
our Chief Executive Officer, reviews financial information on an aggregate basis
for purposes of allocating resources and evaluating financial performance.
Off-Balance Sheet Arrangements
We do not have any off-balance sheet arrangements or any holdings in variable
interest entities.
Critical Accounting Policies
In preparing our financial statements in accordance with GAAP, we are required
to make estimates and assumptions that affect the amounts of assets,
liabilities, revenue, costs and expenses, and disclosure of contingent assets
and liabilities that are reported in the financial statements and accompanying
disclosures. We evaluate our estimates and assumptions on an ongoing basis. Our
estimates are based on historical experience and various other assumptions that
we believe to be reasonable under the circumstances. Our actual results may
differ from these estimates and assumptions. To the extent that there are
differences between our estimates and actual results, our future financial
statement presentation, financial condition, results of operations and cash
flows will be affected.
We believe that the estimates, assumptions and judgments involved in the
accounting policies described below have the greatest potential impact on our
financial statements because they involve the most difficult, subjective or
complex judgments about the effect of matters that are inherently uncertain.
Therefore, we consider these to be our critical accounting policies.
Accordingly, we evaluate our estimates and assumptions on an ongoing basis. Our
actual results may differ from these estimates and assumptions. See   Note 2.
Summary of Significant Accounting Policies, to the Notes to Consolidated
Financial Statements included elsewhere in this report for information about
these critical accounting policies as well as a description of our other
accounting policies.
Revenue Recognition
While our revenue recognition does not involve significant judgment, it
represents an important accounting policy. Our revenues are generated through
sales of our products to distributors or customers. Revenue is recognized at the
point in which the performance obligation under the terms of a contract with the
customer have been satisfied and control has transferred. The Company's
performance obligation is typically defined as the accepted purchase order, or
the contract, with the customer which requires the Company to deliver the
requested
                                       81
--------------------------------------------------------------------------------

products at agreed upon prices at the time and location of the customer's
choice. The Company does not offer warranties or a right to return on the
products it sells except in the instance of a product recall.
Revenue is measured as the amount of consideration the Company expects to
receive in exchange for fulfilling the performance obligation. Sales and other
taxes the Company collects concurrent with the sale of products are excluded
from revenue. The Company's normal payment terms vary by the type and location
of its customers and the products offered. The time between invoicing and when
payment is due is not significant. None of the Company's customer contracts as
of December 31, 2020 contains a significant financing component.
The Company routinely offers sales discounts and promotions through various
programs to its customers and consumers. These programs include rebates,
temporary on shelf price reductions, off invoice discounts, retailer
advertisements, product coupons and other trade activities. Provision for
discounts and incentives are recorded in the same period in which the related
revenues are recognized. At the end of each accounting period, the Company
recognizes a liability for estimated sales discounts that have been incurred but
not paid. The offsetting charge is recorded as a reduction of revenues in the
same period when the expense is incurred.
The Company recognizes the incremental costs of obtaining contracts as an
expense when incurred if the amortization period of the assets that the Company
otherwise would have recognized is one year or less. The incremental cost to
obtain contracts was not material.
Asset Acquisition and Purchase Price Allocation
We follow the guidance in ASC 805, Business Combinations, for determining
whether an acquisition meets the definition of a business combination or asset
acquisition. ASC 805-10-55-5A through 5C provides a practical screen test to
determine if substantially all the fair value of the assets acquired, generally
90% of the total fair value of assets acquired, is concentrated in a single
asset or group of similar assets. If the initial screening test is met, the
transaction is considered an asset acquisition and not a business combination.
If the initial screening test is not met, further assessment is necessary to
determine if the following are present-outputs, inputs and substantive
processes, an organized workforce to convert existing inputs into output. Based
on the results of this analysis and conclusion on an acquisition's
classification of a business combination or asset acquisition, the accounting
treatment is determined. We use considerable judgment in determining whether the
acquisition of a pool of assets is an acquisition of assets or of a business.
Because acquisition costs are expensed for an acquisition of a business and
capitalized for an acquisition of assets, results of operations could be
materially different based on our determination.
For acquisitions that are accounted for as acquisitions of assets, we record the
acquired tangible and intangible assets and assumed liabilities, if any, based
on each asset's and liability's relative fair value at the acquisition date to
the total purchase price plus capitalized acquisition costs.
Emerging Growth Company Status
Effective December 31, 2020, we lost our EGC status and are now categorized as a
Large Accelerated Filer based upon the current market capitalization of the
Company according to Rule 12b-2 of the Exchange Act. As a result, we must comply
with all financial disclosure and governance requirements applicable to Large
Accelerated Filers.
Recently Adopted Accounting Pronouncements
Please refer to   Note 2  , Summary of Significant Accounting Policies, to the
Notes to Consolidated Financial Statements included elsewhere in this report for
a discussion of recently adopted accounting pronouncements and new accounting
pronouncements that may impact us.


                                       82

--------------------------------------------------------------------------------

© Edgar Online, source Glimpses